Evaluation-Driven Integrative Oncology Approach Using Activated Charcoal Carbon Nanoparticle Nanocolloid Solution (ACCNNS)and Panch Shakti Herbal Formulation for Tumor Microenvironment Modulation

GLYCYRRHIZA GLABRA (mulethi)

Ocemum Sanctum (Tulsi)

Punarnava (Boerhavia Diffusa)

Vinca rosea (Sadabahar)

Ginseng (Korean/Asian Ginseng (Panax ginseng) and American Ginseng)

Evaluation-Driven Integrative Oncology Approach Using Activated Charcoal Carbon Nanoparticle Nanocolloid Solution and Panch Shakti Herbal Formulation for Tumor Microenvironment Modulation 

Abstract

The tumor microenvironment (TME) plays a critical role in cancer progression and therapeutic resistance. This paper proposes a novel, hypothesis-driven integrative oncology approach combining localized administration of Activated Charcoal Carbon Nanoparticles Nanocolloid Solution (ACCNNS) with a multi-herbal formulation termed Panch Shakti. The proposed mechanism involves modulation of immune components, particularly macrophages and white blood cells (WBCs), alongside supportive systemic effects from herbal bioactives. The intervention is conceptualized as an adjunct to conventional therapies including chemotherapy and radiotherapy. While grounded in emerging fields such as nanomedicine and phytopharmacology, this approach remains theoretical and requires rigorous preclinical and clinical validation.

PART-1 USE OF ACTIVATED CHARCOAL CARBON NANOPARTICLE NANOCOLLOID SOLUTION (ACCNNS)TO DISABLE TUMOR GROWTH THROGH WBC AND MACROPHASE IMMUNE SYSTEM IN REVERSE MOA THE TECHNIQUE OF FILLING ACFNS IN TUMOR GROVING TECHNIQUE BY INCITION SURGERY ALONG WITH CONVENTIONAL RADIATION ,CHEMO THERAPY & ANTIBIOTICS SUPPORTS

PART 2 HERBAL MEDICINE THE PANCH SHAKTI - 1. NAYANTARA 2. TULSI 3. MULETHI 4. PUNARNAVA 5. GINSENG ALL INGREDIENTS PASTE APPLIED LOCAL INTRADERMAL TUMOR OF PART 1

AND CONSUMED SYRUP OF THE PANCH SHAKTI FORMULATION TOGETHER AS PER INDICATION

ACTIVATED CHARCOAL CARBON 

Keywords

Tumor microenvironment, activated charcoal carbon nanoparticles & Nanocolloids solution (ACCNNS), macrophages, immunomodulation, integrative oncology, herbal medicine, nanomedicine, 

1. Introduction

Cancer progression is strongly influenced by the tumor microenvironment (TME), which includes immune cells, stromal elements, and signaling molecules (Hanahan & Weinberg, 2011). Among immune cells, macrophages play a dual role, with M1 phenotypes exhibiting anti-tumor activity and M2 phenotypes promoting tumor growth (Mantovani et al., 2002).

Recent advances in oncology include:

Nanoparticle-based drug delivery systems

Immunotherapy targeting immune checkpoints

Integrative medicine approaches combining herbal and conventional therapies

This study proposes a novel integrative model combining:

Localized nanocarbon intervention (ACFNS)

Panch Shakti herbal formulation

The concept of a “Panch Shakti Rasayana” combining five potent medicinal plants—Sadabahar, Tulsi, Punarnava, Mulethi, and Ginseng—represents a multi-target, synergistic herbal approach acting on immunity, metabolism, inflammation, and cellular protection. Below is a detailed pharmacological explanation of each component and their combined action.

🌿 Panch Shakti Rasayana – Pharmacological Actions

I. Catharanthus roseus (Sadabahar / Nayantara)

🔬 Active Constituents:

Alkaloids: Vincristine, Vinblastine

Flavonoids, tannins

⚙️ Pharmacological Actions:

Anticancer (Cytotoxic):

Vincristine and vinblastine inhibit microtubule formation → block mitosis in cancer cells.

Antidiabetic:

Enhances insulin secretion and glucose uptake.

Antioxidant:

Neutralizes free radicals, reducing oxidative stress.

Antimicrobial:

Active against bacteria and fungi.

II. Ocimum sanctum (Tulsi / Holy Basil)

🔬 Active Constituents:

Eugenol, Ursolic acid, Rosmarinic acid

⚙️ Pharmacological Actions:

Immunomodulator:

Enhances T-cell and macrophage activity.

Adaptogen:

Reduces stress via cortisol regulation.

Anti-inflammatory:

Inhibits COX-2 and LOX pathways.

Antimicrobial & Antiviral

Cardioprotective & Antidiabetic

III. Boerhaavia diffusa (Punarnava)

🔬 Active Constituents:

Punarnavine, Boeravinones, lignans

⚙️ Pharmacological Actions:

Diuretic & Nephroprotective:

Enhances kidney filtration and reduces edema.

Anti-inflammatory:

Inhibits pro-inflammatory cytokines.

Hepatoprotective:

Protects liver cells from toxins.

Antioxidant

Immunomodulatory

IV. Glycyrrhiza glabra (Mulethi / Licorice)

🔬 Active Constituents:

Glycyrrhizin, Liquiritigenin, flavonoids

⚙️ Pharmacological Actions:

Anti-inflammatory:

Mimics corticosteroid-like action.

Immunomodulator:

Enhances interferon production.

Anti-ulcer & Gastroprotective

Antiviral:

Active against respiratory viruses.

Antioxidant

IV. Panax ginseng (Ginseng)

🔬 Active Constituents:

Ginsenosides (Rb1, Rg1)

⚙️ Pharmacological Actions:

Adaptogen:

Improves resistance to stress and fatigue.

Immunomodulator:

Stimulates NK cells and macrophages.

Neuroprotective:

Enhances cognition and memory.

Antioxidant

Antidiabetic & Cardioprotective

🔗 Synergistic Pharmacological Effects (Combined Action)

A. 🛡️ Immunomodulation (Core Rasayana Effect)

Tulsi + Ginseng → ↑ T-cells, NK cells

Mulethi → ↑ interferon response

Punarnava → macrophage activation

👉 Net Effect: Strong innate + adaptive immunity

B. 🔥 Anti-inflammatory & Anti-oxidative Shield

All 5 herbs reduce ROS (Reactive Oxygen Species)

Downregulation of TNF-α, IL-6 👉 Protects against chronic diseases (cancer, diabetes, CVS disorders)

C. 🧬 Anticancer Potential (Adjunct Role)

Sadabahar → direct cytotoxic action

Tulsi + Ginseng → apoptosis induction

Punarnava → anti-proliferative

👉 May support chemotherapy (NOT a replacement)

D. 🧠 Adaptogenic & Neuroendocrine Balance

Ginseng + Tulsi regulate HPA axis 👉 Reduces stress, improves hormonal balance

E.  🫀 Cardio-Renal-Metabolic Protection

Punarnava → kidney function

Tulsi + Ginseng → lipid & glucose control

Mulethi → vascular protection

👉 Useful in diabetes, hypertension, renal disorders

F. 🧫 Detoxification & Organ Protection

Liver (Punarnava)

Gut (Mulethi)

Cellular detox (All antioxidants)

⚠️ Important Scientific & Safety Notes

Sadabahar alkaloids (vincristine/vinblastine) are potent chemotherapy drugs → raw plant use must be cautious.

Mulethi in excess → can cause hypertension (pseudoaldosteronism).

Ginseng → may interact with anticoagulants.

Clinical validation of combined Rasayana formulation is still limited.

 Conclusion

The Panch Shakti Rasayana acts as a multi-system pharmacological formulation with:

Immunomodulatory

Antioxidant

Anti-inflammatory

Adaptogenic

Organ-protective

Adjunct anticancer potential

It aligns with Ayurvedic Rasayana principles but requires modern clinical trials for validation, dosage standardization, and safety profiling.

2. Rationale

2.1 Nanocarbon in Oncology

Carbon-based nanomaterials have been investigated for:

Drug delivery

Photothermal therapy

Imaging applications (Liu et al., 2008)

Their high surface area enables adsorption of biomolecules and potential interaction with cellular systems.

2.2 Herbal Pharmacology

Medicinal plants contain bioactive compounds with:

Antioxidant

Anti-inflammatory

Immunomodulatory properties (Cragg & Newman, 2005)

Notably:

Catharanthus roseus provides alkaloids used in chemotherapy

Ocimum sanctum exhibits immunomodulatory effects

Panax ginseng acts as an adaptogen

3. Hypothesis

Localized administration of ACFNS may alter the tumor microenvironment by interacting with immune cells, while Panch Shakti herbal formulation may enhance systemic immune responses and reduce inflammation, collectively contributing to tumor growth modulation.

4. Materials and Methods (Proposed Framework)

4.1 Study Design

Phase I: In vitro studies

Phase II: Animal models

Phase III: Controlled clinical trials (conditional upon safety validation)

4.2 Intervention Components

4.2.1 Activated Charcoal Carbon Fine Nanocolloid Solution (ACCFNS)

Sterile nanocarbon suspension

Characterization:

Particle size distribution

Surface charge

Biocompatibility

4.2.2 Panch Shakti Herbal Formulation

Composition:

Nayantara (Catharanthus roseus)

Tulsi (Ocimum sanctum)

Mulethi (Glycyrrhiza glabra)

Punarnava (Boerhaavia diffusa)

Ginseng (Panax ginseng)

4.3 Proposed Intervention Protocol

Local Treatment

Controlled tumor exposure (experimental setting only)

Introduction of ACCNNS into tumor mass

Systemic Treatment

Oral Panch Shakti formulation

Adjunct Therapy

Standard chemotherapy

Radiotherapy

Antibiotic prophylaxis

5. Proposed Mechanism of Action

5.1 ACCNNS 

Adsorption of tumor metabolites

Modulation of TME

Interaction with macrophages:

Potential shift toward M1 phenotype

Recruitment of immune cells

5.2 Panch Shakti

Antioxidant effects

Cytokine modulation

Organ system support (hepatic, renal)

Reduction of oxidative stress

6. Expected Outcomes

Modulation of tumor growth kinetics

Enhanced immune response markers

Improved tolerance to conventional therapies

Reduction in systemic inflammation

7. Safety and Risk Assessment

Potential Risks

Local tissue toxicity

Infection

Nanoparticle-induced inflammation

Herb-drug interactions

Required Evaluations

Toxicology studies

Pharmacokinetics

Immunogenicity profiling

8. Discussion

This integrative model aligns with emerging trends in:

Tumor microenvironment targeting

Nanomedicine

Complementary oncology

However, significant challenges remain:

Lack of empirical evidence

Unknown biodistribution of nanocarbon

Variability in herbal preparations

The hypothesis requires validation through:

Controlled laboratory studies

Mechanistic exploration

Clinical trials

9. Limitations

Conceptual framework without experimental data

Safety concerns regarding local nanocarbon administration

Lack of standardization in herbal formulation

10. Conclusion

The proposed integrative approach combining ACCNNS and Panch Shakti represents a novel but unvalidated therapeutic concept. While grounded in scientific principles of nanotechnology and phytopharmacology, it requires rigorous experimental validation before clinical application.

11. References

Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell. 2011.

Mantovani A, et al. Macrophage polarization in tumor progression. Trends Immunol. 2002.

Liu Z, et al. Carbon nanomaterials in biomedical applications. Nano Research. 2008.

Cragg GM, Newman DJ. Plants as a source of anti-cancer agents. J Ethnopharmacol. 2005.

Newman DJ, Cragg GM. Natural products as sources of new drugs. J Nat Prod. 2016.

Aggarwal BB, et al. Role of herbal medicine in cancer prevention. Biochem Pharmacol. 2006.

Gupta SC, et al. Multitargeting by phytochemicals. Cancer Lett. 2010.

Peer D, et al. Nanocarriers as an emerging platform for cancer therapy. Nat Nanotechnol. 2007.

Suresh AK, Pelletier DA, Wang W, et al. Silver nanoparticle toxicity. Environ Sci Technol. 2010.

Efferth T, Koch E. Complex interactions between phytochemicals and cancer cells. Curr Drug Targets. 2011.